AFP and hepatocellular carcinoma: Combining gender (biological sex) and age with the established biomarkers AFP and PIVKA-II in a single diagnostic algorithm has the potential to improve the differentiation of early-stage HCC from benign CLD versus AFP and PIVKA-II alone.